High Tower Advisors, LLC Evolus, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.36 - $13.67 $79,907 - $148,415	-10,857 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$8.42 - $13.96 $4,210 - $6,980	500 Added 4.83%	10,857 $137,000
Q1 2021 May 10, 2021	BUY	$3.2 - $16.51 $33,142 - $170,994	10,357 New	10,357 $134,000
Q3 2019 Nov 12, 2019	SELL	$13.91 - $19.87 $165,737 - $236,751	-11,915 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.19 - $28.36 $157,158 - $337,909	11,915 New	11,915 $175,000

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $711M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.